Yuping Suo
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Aspartame triggers premature ovarian failure via SIRT1-dependent suppression of the PI3K/AKT/mTOR pathway and induction of oxidative stress and apoptosis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: May 27, 2026
INHBA secreted by cancer-associated fibroblasts promotes cisplatin resistance and malignant progression of ovarian cancer via ENG-mediated suppression of apoptosis and induction of EMT.
Journal: Journal of translational medicine
Published: August 26, 2025
Knockdown of TOP2A reverses cisplatin resistance in ovarian cancer by inhibiting EMT via ferroptosis mediated by the TP53/GPX4/SLC7A11 axis.
Journal: Frontiers in immunology
Published: July 29, 2025
Paeonol protects against cisplatin-induced premature ovarian failure via anti-inflammatory and antioxidant activities: an integrated approach of network pharmacology, molecular dynamics simulation, and experimental validation.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 24, 2025
DDIAS promotes endometrial cancer progression via β-catenin signaling.
Journal: PloS one
Published: March 04, 2025
Studies related to the enhanced the effect of 5-aminolevulinic acid-based photodynamic therapy combined with tirapazamine.
Journal: Photodiagnosis and photodynamic therapy
Published: April 06, 2024
Cell Cycle-Related Centromere Protein F Deficiency Suppresses Ovarian Cancer Cell Growth by Inducing Ferroptosis.
Journal: Gynecologic and obstetric investigation
Published: September 04, 2023
Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer.
Journal: Journal of ginseng research
Published: November 16, 2022
Last Updated: 09/26/2026